MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about disclosure

18 Sep 2024 Evaluate
Jagsonpal Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Infinity Portfolio Holdings.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1752.40
Dr. Reddys Labs. 1233.30
Cipla 1331.00
Lupin 1968.55
Zydus Lifesciences 1124.80
View more..